AOTI, Inc.
LSE: AOTI.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Michael Griffiths
- Employees
- 85
- Headquarters
- Oceanside, United States
- IPO year
- 2024
- Market cap
- £69.1M
- Website
- http://aotinc.net
Loading AOTI…
Loading profile data…Frequently asked questions about AOTI
What does AOTI, Inc. (AOTI.L) do?
AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.
Where does AOTI.L trade?
AOTI, Inc. (AOTI.L) trades on the London Stock Exchange.
What sector is AOTI.L in?
AOTI, Inc. (AOTI.L) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of AOTI, Inc.?
Michael Griffiths is the chief executive officer of AOTI, Inc. (AOTI.L).
Where is AOTI, Inc. headquartered?
AOTI, Inc. is headquartered in United States.
Does AOTI.L pay a dividend?
AOTI, Inc. (AOTI.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AOTI.L go public?
AOTI, Inc. (AOTI.L) completed its initial public offering in 2024.